Safety and efficacy of ruxolitinib in adult patients with polycythemia vera: A multicenter observational study
Latest Information Update: 29 Dec 2020
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Polycythaemia vera
- Focus Adverse reactions; Therapeutic Use
- 08 Dec 2020 Interim results (n=150) presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology
- 20 Jul 2020 New trial record
- 21 Jun 2020 Interim results (n=60) presented at the 25th Congress of the European Haematology Association.